These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 38134088)

  • 1. Risk factors of systemic lupus erythematosus patients with pulmonary arterial hypertension: A systematic review and meta-analysis.
    Lun X; Yang J; Liu Y; Zhao F; Wei Z; Sun Y; Zhou X
    Medicine (Baltimore); 2023 Dec; 102(51):e36654. PubMed ID: 38134088
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Risk factors of pulmonary arterial hypertension in patients with systemic lupus erythematosus: A meta-analysis.
    Liu Y; Cheng Z; Zha B; Chen X; Gong Z; Ji L; Wei L
    Lupus; 2023 Oct; 32(11):1310-1319. PubMed ID: 37699157
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pulmonary arterial hypertension in systemic lupus erythematosus based on a CSTAR-PAH study: Baseline characteristics and risk factors.
    Zhang N; Li M; Qian J; Wang Q; Zhao J; Yang Z; Tian Z; Zhang X; Zuo X; Zhang M; Zhu P; Ye S; Zhang W; Zheng Y; Qi W; Li Y; Zhang Z; Ding F; Gu J; Liu Y; Wei W; Zeng X
    Int J Rheum Dis; 2019 May; 22(5):921-928. PubMed ID: 30746850
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Clinical analysis of patients with systemic lupus erythematosus and concomitant pulmonary hypertension].
    Luo RQ; Lei YX; Zhang X; Liang F
    Nan Fang Yi Ke Da Xue Xue Bao; 2008 Oct; 28(10):1860-3. PubMed ID: 18971190
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Baseline Characteristics and Risk Factors of Pulmonary Arterial Hypertension in Systemic Lupus Erythematosus Patients.
    Huang C; Li M; Liu Y; Wang Q; Guo X; Zhao J; Lai J; Tian Z; Zhao Y; Zeng X
    Medicine (Baltimore); 2016 Mar; 95(10):e2761. PubMed ID: 26962774
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Features associated with pulmonary arterial hypertension in Chinese hospitalized systemic lupus erythematosus patients.
    Xu SZ; Yan Liang ; Li XP; Li XM; Shuai ZW; Leng RX; Pan HF; Ye DQ
    Clin Rheumatol; 2018 Jun; 37(6):1547-1553. PubMed ID: 29520672
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical features and independent predictors of pulmonary arterial hypertension in systemic lupus erythematosus.
    Lian F; Chen D; Wang Y; Ye Y; Wang X; Zhan Z; Xu H; Liang L; Yang X
    Rheumatol Int; 2012 Jun; 32(6):1727-31. PubMed ID: 21437686
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chinese SLE Treatment and Research group (CSTAR) registry VII: prevalence and clinical significance of serositis in Chinese patients with systemic lupus erythematosus.
    Zhao J; Bai W; Zhu P; Zhang X; Liu S; Wu L; Ma L; Bi L; Zuo X; Sun L; Huang C; Tian X; Li M; Zhao Y; Zeng X;
    Lupus; 2016 May; 25(6):652-7. PubMed ID: 26762471
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nailfold capillaroscopy as a risk factor for pulmonary arterial hypertension in systemic lupus erythematosus patients.
    Donnarumma JFS; Ferreira EVM; Ota-Arakaki J; Kayser C
    Adv Rheumatol; 2019 Jan; 59(1):1. PubMed ID: 30657102
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chinese SLE Treatment and Research group (CSTAR) registry: II. Prevalence and risk factors of pulmonary arterial hypertension in Chinese patients with systemic lupus erythematosus.
    Li M; Wang Q; Zhao J; Li Z; Ye Z; Li C; Li X; Zhu P; Wang Z; Zheng Y; Li X; Zhang M; Tian Z; Liu Y; He J; Zhang F; Zhao Y; Zeng X;
    Lupus; 2014 Sep; 23(10):1085-91. PubMed ID: 24651670
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Predictive factors for concomitant pulmonary arterial hypertension at diagnosis of systemic lupus erythematosus in a Chinese population.
    Pan Y; Sun Y; He L
    Int J Rheum Dis; 2022 Jan; 25(1):76-82. PubMed ID: 34796660
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prevalence, risk factors and echocardiographic predictors of pulmonary hypertension in systemic lupus erythematosus: towards a screening protocol.
    Álvarez Troncoso J; Soto Abánades C; Robles-Marhuenda Á; Alcolea Batres S; Fernández Velilla Peña M; Jiménez Valero S; Sorriguieta Torre R; Rios-Blanco JJ
    RMD Open; 2024 Jan; 10(1):. PubMed ID: 38191213
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Incidence and survival impact of pulmonary arterial hypertension among patients with systemic lupus erythematosus: a nationwide cohort study.
    Chen HA; Hsu TC; Yang SC; Weng CT; Wu CH; Sun CY; Lin CY
    Arthritis Res Ther; 2019 Mar; 21(1):82. PubMed ID: 30917868
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Risk factors of pulmonary arterial hypertension in patients with systemic lupus erythematosus.
    Lei Y; Zhang X; Feng Y; Wang J; Luo R
    Cardiol Young; 2021 Oct; 31(10):1619-1624. PubMed ID: 33682659
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pulmonary arterial hypertension in systemic lupus erythematosus: current status and future direction.
    Dhala A
    Clin Dev Immunol; 2012; 2012():854941. PubMed ID: 22489252
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Circulating extracellular vesicles as novel biomarkers for pulmonary arterial hypertension in patients with systemic lupus erythematosus.
    Ding Z; Qi F; Liu L; Wang Z; Zhang N; Lyu X; Sun W; Du J; Song H; Hou H; Guo Y; Wang X; Liu ML; Wei W
    Front Immunol; 2024; 15():1374100. PubMed ID: 39364410
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pulmonary Arterial Hypertension Associated With Systemic Lupus Erythematosus: Results From the French Pulmonary Hypertension Registry.
    Hachulla E; Jais X; Cinquetti G; Clerson P; Rottat L; Launay D; Cottin V; Habib G; Prevot G; Chabanne C; Foïs E; Amoura Z; Mouthon L; Le Guern V; Montani D; Simonneau G; Humbert M; Sobanski V; Sitbon O;
    Chest; 2018 Jan; 153(1):143-151. PubMed ID: 28851621
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pulmonary hypertension on systemic sclerosis-lupus erythematosus overlap syndrome.
    Rachdi I; Tougorti M; Daoud F; Aydi Z; Zoubeidi H; Ben Dhaou B; Boussema F
    Ann Cardiol Angeiol (Paris); 2019 Oct; 68(4):221-225. PubMed ID: 30685083
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-term prognosis of patients with systemic lupus erythematosus-associated pulmonary arterial hypertension: CSTAR-PAH cohort study.
    Qian J; Li M; Zhang X; Wang Q; Zhao J; Tian Z; Wei W; Zuo X; Zhang M; Zhu P; Ye S; Zhang W; Zheng Y; Qi W; Li Y; Zhang Z; Ding F; Gu J; Liu Y; Wang Y; Zeng X;
    Eur Respir J; 2019 Feb; 53(2):. PubMed ID: 30635295
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A prognostic model for systemic lupus erythematosus-associated pulmonary arterial hypertension: CSTAR-PAH cohort study.
    Qu J; Li M; Zhang X; Zhang M; Zuo X; Zhu P; Ye S; Zhang W; Zheng Y; Qi W; Li Y; Zhang Z; Ding F; Gu J; Liu Y; Qian J; Huang C; Zhao J; Wang Q; Liu Y; Tian Z; Wang Y; Wei W; Zeng X
    Respir Res; 2023 Sep; 24(1):220. PubMed ID: 37689662
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.